Injective has officially announced the launch of its inEVM Layer 2 rollup solution on its mainnet, marking a significant milestone after a successful testnet phase.

This launch is part of Injective's strategic vision to create a network of 'Electro Chains' that not only expands its Layer 2 ecosystem but also promotes interoperability across various blockchains. The inEVM represents the first Ethereum Virtual Machine rollup capable of achieving true composability between Cosmos and Solana, setting a new standard in the blockchain space.

Eric Chen, the CEO and co-founder of Injective Labs, emphasized the revolutionary nature of inEVM, highlighting its potential to scale on-chain finance to meet the demands of traditional finance on a global scale.

This solution allows Ethereum developers to seamlessly deploy their applications, such as decentralized exchanges, on Injective without any need for code modifications.

The launch underscores Injective's commitment to fostering collaboration within the blockchain community and providing developers with the tools they need to innovate.

The testnet phase of inEVM, conducted in partnership with Caldera, provided valuable insights, revealing the significant impact of enabling Ethereum applications to run natively on the network without alterations to their existing contracts.

Despite the initial plan to launch the inEVM mainnet in the last quarter of the previous year, Chen explained that the delay was strategic, aimed at ensuring the readiness of the developer community and the optimal deployment of dApps.

The inEVM mainnet launch will see the integration of projects such as Celestia, Pyth, TimeSwap, and Thetanauts, further enriching the Injective ecosystem. This launch follows the establishment of a $150 million ecosystem fund by Injective Labs, supported by leading names in the industry including Pantera, Jump Crypto, and Kraken Ventures.

This fund underscores the broad industry support for Injective's vision and its commitment to driving the future of decentralized finance.

As the blockchain community anticipates the widespread adoption of inEVM, Injective Labs continues to push the boundaries of what's possible in blockchain interoperability and scalability.

The launch of inEVM is not just a testament to Injective's innovative spirit but also a beacon for the future of decentralized applications, offering a scalable, interoperable platform that bridges the gap between various blockchain ecosystems.